Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Revenue: 2020-2025

Historic Revenue for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to $7.0 million.

  • Biofrontera's Revenue fell 22.46% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 5.11%. This contributed to the annual value of $37.3 million for FY2024, which is 9.54% up from last year.
  • As of Q3 2025, Biofrontera's Revenue stood at $7.0 million, which was down 22.61% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Revenue registered a high of $12.6 million during Q4 2024, and its lowest value of $4.3 million during Q3 2022.
  • Its 3-year average for Revenue is $8.7 million, with a median of $8.7 million in 2023.
  • Per our database at Business Quant, Biofrontera's Revenue slumped by 76.92% in 2021 and then soared by 105.83% in 2023.
  • Over the past 5 years, Biofrontera's Revenue (Quarterly) stood at $9.2 million in 2021, then grew by 10.65% to $10.1 million in 2022, then grew by 4.46% to $10.6 million in 2023, then grew by 18.53% to $12.6 million in 2024, then dropped by 22.46% to $7.0 million in 2025.
  • Its Revenue was $7.0 million in Q3 2025, compared to $9.0 million in Q2 2025 and $8.6 million in Q1 2025.